Reserve Bank of India – Press Releases
[ad_1]
Read More/Less
|
|
[ad_2]
Get Bank IFSC & MICR codes here.
[ad_1]
|
|
[ad_2]
[ad_1]
Poonawalla Fincorp and CARS24 on Monday announced their strategic partnership for quick and seamless consumer financing on vehicles bought from CARS24.
CARS24 raises $450 million funding in Series F round
“In this partnership, Poonawalla Fincorp will fulfil consumer loans originating through CARS24. Additionally, both parties will partake in the risk and rewards,” they said in a statement.
Vijay Deshwal, Group Chief Executive officer, Poonawalla Fincorp Ltd, said, “With technology at its core, we at Poonawalla Fincorp aim to create a digitally-enabled consumer lending platform and this partnership with CARS24 is a step in that direction. We are optimistic that this will be a great partnership and will provide hassle-free experience to customers in fulfilling their dream of owning a car.”
Cars24 eyes 20% share of the used car market in 5 years
Ruchit Agarwal, Co-founder and CFO, CARS24, said, “With only 20 per cent consumer financing penetration in the used cars industry, we feel that there is a huge market opportunity waiting to be tapped.”
[ad_2]
[ad_1]
The Current Market Price (CMP) of Laurus Labs is Rs. 482. The brokerage firm, Motilal Oswal has estimated a Target Price for the stock at Rs. 690. Hence the stock is expected to give a 15% return, in a Target Period of 1 year.
Stock Outlook | |
---|---|
Current Market Price (CMP) | Rs. 482 |
Target Price | Rs. 690 |
1 year return | 43.00% |
Additionally, Laurus Labs (LAURUS) has agreed to acquire a 26.6% stake in ImmunoACT for a consideration of Rs. 460m, implying an enterprise value of Rs. 1.7b. ImmunoACT currently has four CAR-T cell molecules, with one of them undergoing clinical trials. CAR-T cell is a new therapy for Leukemia/Lymphoma, with USD 1.5b in worldwide sales of five commercialized products. The brokerage firm mentioned, “Given that ImmunoACT products are under development, the commercialization would be subject to a successful clinical outcome. However, this represents LAURUS’ entry for a potential CDMO opportunity into a new therapy space over the next 4-5 years.”
Motilal Oswal maintained BUY rating for the stock and said, “We remain positive on LAURUS on the back of a scale-up in CDMO (Synthesis/Biologics), market share gains in the Non-ARV segment, and growth potential in the Non-ARV business. We continue to value LAURUS at 24x 12M forward earnings to arrive at a Target Price of Rs. 690.”
Laurus Labs develops innovative medicines, and they work with the top 10 generic pharmaceutical companies globally. They sell APIs in 56 countries, while their major focus areas include anti-retroviral, Hepatitis C, and Oncology drugs. The company undertakes dedicated R&D in areas that have significant growth potential.
The above stock was picked from the brokerage report of Motilal Oswal. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.
[ad_2]
[ad_1]
HDFC Securities has said in its research report that “GSL, in Q1FY22, reported net revenue growth of 61% to Rs 371 Cr backed by an increase in the share of Rajasthan Medium Liquor (RML) in the Consumer Business segment and higher sales volume of 29.9 Mn liters in Bulk Alcohol Segment. EBITDA Margin grew for the 6th consecutive quarter and stood at a record high of 26.5% – up 940/183 bps YoY/QoQ in Q1FY22 on account of higher RML share in Consumer Business and better realizations. Bulk Alcohol sales volumes stood at 29.9 Mn litre in Q1FY22, up 45% YoY and 5% QoQ. The average realization for bulk alcohol came in at Rs. 51.6 per litre in Q1FY22. The share of Consumer Business grew to 42% in Q1FY22 from ~35% in Q1FY21, on the back of both volume and value growth.”
The company’s “Value Segment sales volumes grew by 65% YoY to 3.3 Mn cases and realisations by 16% YoY and 10% QoQ to Rs 462.5 per case in Q1FY22. Despite the 2nd wave of Covid-19, the Capacity Utilization in Q1FY22 stood at 98% (vs 58% in Q1FY21 and 99% in Q4FY21). On the expansion front, in West Bengal, expansion work of an additional 140 KLPD is nearing completion and likely to be commissioned in Q3FY22. In Jharkhand, work has commenced on a planned expansion of 140 KLPD and the project is expected to be commissioned in FY23. Additional 140 KLPD expansion is under evaluation between Bihar and another location; work expected to start later in FY22” said the brokerage.
The brokerage has said that the company’s “Net revenues/ EBITDA/ PAT have grown at a CAGR of 15%/40%/94% over the last 5 years with EBITDA/PAT margin expanding from 9.5%/1.4% to 20.7%/11.4%. In fact the company has reported EBITDA margin expansion over the past 6 consecutive quarters, with it reaching a high of 26.5% in Q1FY22. Stable working capital, lower cash outlay for tax due to availability of MAT credit and a reduction in interest cost led CFO to improve to Rs 148.4 Cr in FY21 from Rs. 30.6 Cr in FY19. The company strengthened its balance sheet by reducing the debt of Rs. 75 Cr despite ongoing CAPEX. Robust cash flow generation will further aid debt reduction.”
HDFC Securities claims that “Going ahead, we expect GSL’s Net Revenues/EBITDA/ PAT to witness a strong CAGR growth of 21%/23%/28% over FY21-24E driven by capacity expansion in bulk alcohol and faster growth in IMIL business, led by increasing pricing gap vs. IMFL players in key states and the emergence of the ‘premium country liquor’ (medium liquor), which in our opinion is a game changer. Medium liquor realisations are ~50% higher than the value segment and offer strong growth and upgrading opportunities across the company’s key markets. While its foray in premium IMFL (highly margin accretive) through Unibev is at a nascent stage, a successful ramp-up here can drive the profitability.”
HDFC Securities has clarified in its research report that “Govt’s aim of 20% blending target by 2025 has created sheer supply-deficit of Ethanol (details inside) and has led to the diversion of ENA towards ethanol, creating structural support for ENA prices. While GSL may witness some moderation in margins (from 26.5% in Q1FY22), we expect the company to maintain 20%+ over near to mid-term, driven by higher realizations for bulk alcohol and benign input costs. Robust sales growth and improvement in profitability coupled with stable working capital is likely to aid higher cash flow generation in the coming years. We expect GSL to generate strong cumulative cash flows of ~Rs. 900 Cr to be utilised for its ongoing and future CAPEX programmes and, debt reduction.”
The brokerage has further stated that “Though the stock has rallied ~4x over the past 6 months, we believe there’s still upside to this rally, with the caveat that the Government maintains its supportive stance on ethanol blending. We think the base case fair value of the stock is Rs 1,619 (17x Sept’23E EPS) and the bull case fair value is Rs 1,761 (18.5x Sept’23E E EPS). Investors can buy the in stock Rs 1,454-1,482 band (15.5x Sept’23E EPS) and add more on dips to Rs 1,273-1,297 band (13.5x Sept’23E EPS). At LTP of Rs 1,469, it quotes at 15.4x Sept’23E EPS.”
The stock has been picked from the brokerage report of HDFC Securities Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.
[ad_2]
[ad_1]
Asset quality pains for banks have largely eased after the second quarter and they are now likely to focus on growth, believe analysts.
A report by ICICI Securities noted that overall the quarter ended September 30, 2021 saw improvement in broad business parameters and management commentaries have been positive suggesting better traction in the second half of the fiscal.
“We believe profitability should see a boost in coming quarters with better top-line growth and lower provisions. Loan growth is to be largely driven by retail and MSME segment while corporate segment should witness gradual pick up in working capital utilisation,” it said.
Also read: NPAs of NBFCs, HFCs may rise for 3-4 quarters due to tweak in norms
Asset quality performance was better than previous quarter with less slippages and better recoveries, the report said.
Slippages were mostly at about 1- 1.4 per cent compared to 2-2.5 per cent quarter-on-quarter while gross non performing assets declined by 30 to 70 basis points, except for a few banks.
With the opening up of the economy and normalisation of business activities, most banks have reported better collection efficiencies as well as higher credit demand.
“The asset quality pain for most banks is largely behind and the focus now is on the growth acceleration. The one-off gains helped public sector banks to maintain a strong profitability; whereas the private banks’ performance was a shade better than the first quarter,” said a report by Emkay Global Financial Services.
The second quarter of the fiscal was marked by sequential moderation in stress formation, mainly led by retail, and more so for large private and public sector banks, the report said, adding that it expects non performing asset ratios to moderate due to lower slippages and higher recovery and write offs as most banks, barring a few small private banks, sit on a comfortable provision cover.
Motilal Oswal in a report also said that the asset quality outlook for public sector banks is improving gradually after a prolonged corporate NPL cycle – GNPA ratios had reached the peak of about 15 per cent in 2017-18.
A recent report by CARE Ratings had also noted that the NPA situation of the Indian banking system as represented by 23 banks – 9 PSBs and 14 private sector lenders, indicates a gradual improvement in the NPA ratio in September 2021.
The NPA ratio for these 23 banks was 6.97 per cent as on September 30, 2021 compared to 7.36 per cent as on September 30, 2020.
[ad_2]
[ad_1]
“Beware of fraudulent customer care numbers. Please refer to the official website of SBI for correct customer care numbers. Refrain from sharing confidential banking information with anyone,” said the bank via a tweet on its official Twitter handle.
Our OTP based cash withdrawal system for transactions at SBI ATMs is vaccination against fraudsters. Protecting you… https://t.co/K0INJjpL7k
— State Bank of India (@TheOfficialSBI) 1637469000000
This is not the first time that the bank has issued such advice to its customers. Earlier, there have been instances where customers have been conned by calling the customer care number mentioned on a google search for the bank, on food delivery apps etc.Along with the tweet, the bank has also posted an instructional video online, guiding customers on how they can avoid getting conned.
As per the video, while calling the customer care centre, the account holder should not share personal details i.e. bank account number, debit card details, CVV, One-time password (OTP), ATM PIN etc. The bank also sends SMS to its customers reminding them that SBI never asks for confidential information such as PIN and OTP from customers. Any such calls can be made only by a fraudster. Please do not share personal info.
Further, the customer care numbers should be verified from the bank’s official website before making a call.
If you have received such calls or emails, then such frauds can be reported to the bank by sending an email at report.phishing@sbi.co.in or by calling the cybercrime helpline number.
[ad_2]
[ad_1]
[ad_2]
[ad_1]
The brokerage has said “ICICI Bank reported strong all round performance in Q2FY22. The Net Interest Income (NII) grew by 24.8% YoY and 7% QoQ aided by improvement in the NIM. The Fee Income growth was strong at 21% YoY. OPEX grew 28% YoY and 9% QoQ. Despite this, the core operating profit rose 23.3% YoY and 10.6% sequentially. Net Profit stood at Rs. 55.1 bn, up 29.6%/19.4% YoY/QoQ.”
According to the brokerage’s research report “The bank continued to deliver industry-leading loan growth at 17% YoY, driven by mortgage (+25%) and business banking (+43%). The retail portfolio grew by 20% YoY and 5% QoQ. Excluding the builder portfolio, the domestic corporate portfolio grew by 14% YoY and was flat sequentially. Deposits also reported healthy growth of 17.3% YoY. During the quarter, average current account deposits increased by 35.7% YoY and average savings account deposits by 24.9% YoY. The average CASA ratio improved to 44.1% compared to 43.7% in the June quarter. This has further helped the bank in reducing the cost of funds (12bps QoQ improvement). The cost of funds now stands at industry best level.”
HDFC Securities in its research report has stated that “ICICI Bank has reported strong all round performance in Q2FY22. Asset quality shocks of Q1FY22 were largely reversed during the quarter, with net slippages at 0.1% of loans. With PCR at 80% and non-NPA provisions at 2% of loans, credit costs are likely to remain subdued as the back-book clean-up is nearly complete. There could be higher recoveries in the next two-three years than slippages. We have envisaged 16.7% CAGR in Net Interest Income and 24.8% CAGR in net profit over FY21-FY24E. Further, we have estimated that the loan book would grow at 17% CAGR over this period. We expect NIM to trend around this all-time high level and asset quality might improve further.”
The brokerage further claims that “We feel that investors can buy ICICI bank at Buy at Rs.758-764 and add more at Rs.692-695 band. We expect the Base case fair value of Rs.847 (~2.55xSA ABV Sep-22+SOTP) and the Bull case the fair value of Rs.900 (~2.75xSA ABV Sep-22+SOTP) over the next 2 quarters.”
The stock has been picked from the brokerage report of HDFC Securities Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.
[ad_2]
[ad_1]
|
|
[ad_2]
[ad_1]
This loan is intended to assist couples and families in dealing with the financial stress of planning a wedding. It can be used to cover key wedding expenses such as the venue, guest accommodations, jewellery, food, and decoration. During peak wedding season, interest rates for these loans are usually higher than during the off season. The Personal Loan product will help you finance your dream wedding. It’s intended to be a one-stop shop for all of your financial demands and issues.
Do you want to rebuild your kitchen, replace your old furniture around the house, or perhaps spruce up your patio?
Renovations to a home can be expensive, especially if the modifications are significant. Not everyone has the cash on hand to complete a renovation when they want to, so a Home Renovation Loan is a simple alternative. You can get a Personal Loan for Home Renovation from HDFC Bank and give your house the makeover it deserves. You will not only improve the aesthetic appeal of your property, but you will also increase the value of your home for future sale.
You can take out a travel loan to support your holiday plans without jeopardising your savings and investments. This form of personal borrowing is then referred to as a travel loan. You will be required to present travel documentation in order to qualify for this loan. For example, airline tickets, hotel reservations, passport or visa information for international travel, and so on. With the help of a personal loan, you may take your family on a well-deserved vacation without depleting your funds. Your travel expenses are covered by a personal loan, and the funds can be utilised anywhere and at any time.
You can take out a travel loan to support your holiday plans
Consumer durable loans are also available from banks at no cost EMI. Any consumer durable item, such as a phone, refrigerator, furniture, washing machine, microwave, and so on, can be purchased using this form of loan. The product’s cost is divided into EMIs, which can be returned over a set period of time. Some products may require a deposit or a processing fee, while others do not.
Pension loan
Yes, retirees can take out loans worth at least 7 to 10 times their pension to cover any financial emergency. Typically, this loan can only be obtained from the same bank where the pensioner receives his or her pension.
[ad_2]